Xeris Biopharma’s August 6, 2026 update showed second-quarter revenue rising to US$92.1 million while net loss widened to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results